Daniel J Ma MD
Central Nervous System Cancer, Head & Neck
Assistant Professor, Radiation Oncology, Mayo Medical School
Join to View Full Profile
200 1st St SwRochester, MN 55905
Phone+1 507-284-2511
Dr. Ma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Radiation Oncology, 2007 - 2011
St Elizabeth's Medical Center/Lemuel Shattuck HospitalInternship, Transitional Year, 2006 - 2007- Washington University in St. Louis School of MedicineClass of 2006
Certifications & Licensure
MN State Medical License 2011 - 2025
WI State Medical License 2013 - 2021
MO State Medical License 2007 - 2011
American Board of Radiology Radiation Oncology
Clinical Trials
- Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer Start of enrollment: 2013 Sep 04
- Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC Start of enrollment: 2020 Nov 19
Roles: Contact
Publications & Presentations
PubMed
- De-escalation of Adjuvant Therapy in Operatively Managed HPV Associated Oropharyngeal Carcinoma: Current Status and Future Directions.Daniel Ma, David M Routman
Seminars in Radiation Oncology. 2025-04-01 - Survival, Tumor Control, and Safety Outcomes of Proton Therapy in Sinonasal Cancer Population: A Systematic Review and Meta-Analysis.Srivatsa Surya Vasudevan, Estephania Candelo, Alireza Sharifi, Daniel J Ma, Samir H Patel
Head & Neck. 2025-04-01 - Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial.Jacob J Orme, Henan Zhang, Prashanth Lingamaneni, Yohan Kim, Roxane Lavoie
Nature Communications. 2025-03-13
Authored Content
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- The Debate Surrounding Treatment De-Escalation for HPV-Positive Oropharynx CancerFebruary 2018
- Join now to see all
Press Mentions
Mayo Clinic Q&A Podcast: Head and Neck Cancers Are Becoming Increasingly CommonApril 19th, 2021
Mayo Clinic Researchers to Present Findings at ASTRO Annual MeetingSeptember 18th, 2019
Dose De-Escalation in Adjuvant Chemoradiotherapy for HPV-Associated Oropharyngeal Squamous Cell CarcinomaJune 19th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
